|
USP7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.32849999948215E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.376900E-04 |
| Normal-vs-Stage2 |
1.099060E-03 |
| Normal-vs-Stage3 |
4.01270017214017E-10 |
| Normal-vs-Stage4 |
7.02839997313021E-09 |
| Stage1-vs-Stage2 |
2.231000E-01 |
| Stage1-vs-Stage3 |
2.44569999999777E-05 |
| Stage1-vs-Stage4 |
1.635400E-04 |
| Stage2-vs-Stage3 |
3.079000E-01 |
| Stage2-vs-Stage4 |
2.094200E-01 |
| Stage3-vs-Stage4 |
6.342000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.46879999946204E-07 |
| Normal-vs-AfricanAmerican |
3.635100E-04 |
| Normal-vs-Asian |
2.188800E-01 |
| Caucasian-vs-AfricanAmerican |
8.537400E-01 |
| Caucasian-vs-Asian |
6.123600E-01 |
| AfricanAmerican-vs-Asian |
6.443000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.49300000140684E-08 |
| Normal-vs-Female |
7.631500E-04 |
| Male-vs-Female |
1.336320E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.379900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.202060E-04 |
| Normal-vs-Age(61-80Yrs) |
1.10270000019952E-07 |
| Normal-vs-Age(81-100Yrs) |
1.235220E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.749400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.960400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.134200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.468780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.115900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.927230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.734200E-01 |
| Normal-vs-Grade 2 |
1.977800E-03 |
| Normal-vs-Grade 3 |
2.08279948843426E-10 |
| Normal-vs-Grade 4 |
2.67240000129121E-08 |
| Grade 1-vs-Grade 2 |
2.697000E-01 |
| Grade 1-vs-Grade 3 |
5.062800E-03 |
| Grade 1-vs-Grade 4 |
3.622500E-03 |
| Grade 2-vs-Grade 3 |
2.21169999999882E-05 |
| Grade 2-vs-Grade 4 |
5.763200E-04 |
| Grade 3-vs-Grade 4 |
6.253400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.197700E-04 |
| Normal-vs-ccB subtype |
2.15489999999541E-05 |
| ccA subtype-vs-ccB subtype |
7.020500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.85909999997447E-06 |
| Normal-vs-N1 |
3.378300E-03 |
| N0-vs-N1 |
4.779600E-01 |
|
|
